Suppr超能文献

血吸虫性肝硬化和肝细胞癌患者肝活检中AgNOR计数与DNA倍体分析

AgNORs count and DNA ploidy in liver biopsies from patients with schistosomal liver cirrhosis and hepatocellular carcinoma.

作者信息

Attallah Abdelfattah M, Tabll Ashraf A, El-Nashar Eman, El-Bakry Kadry A, El-Sadany Mohamed, Ibrahim Tallat, El-Dosoky Ibrahim

机构信息

Biotechnology Research Center, New Damietta City, Egypt.

出版信息

Clin Biochem. 2009 Nov;42(16-17):1616-20. doi: 10.1016/j.clinbiochem.2009.07.027. Epub 2009 Aug 12.

Abstract

OBJECTIVES

Argyrophilic nucleolar organizer regions (AgNOR) proteins are a set of argyrophilic nucleolar proteins that accumulate in highly proliferating cells, whereas their expression is very low in nonproliferating cells. The present study aimed to investigate the potential of DNA flow cytometry (FCM) and AgNORs count in the assessment of cellular kinetics of liver cirrhosis and hepatocellular carcinoma.

DESIGN AND METHODS

Small-needle liver biopsies (217) were included and were taken from 84 patients with hepatocellular carcinoma (HCC) (one biopsy from tumor lesion and the other from residual nontumor) liver tissues. Only one biopsy was taken from 49 patients with liver cirrhosis. One part of biopsy was subjected to flow cytometry, and the other, to histopathology and AgNORs counting.

RESULTS

An aneuploidy was shown in 44.5% of liver cirrhosis and in 78.6% of tumor sites. Aneuploid HCC cases showed high AgNORs count compared with diploid cases (3.407+/-1.18 vs. 1.74+/-0.9). An extremely significant increase in AgNORs count in tumor lesion (P<0.001) was found compared with residual liver tissues, liver cirrhosis and normal liver (3.89+/-0.827, 1.49+/-0.52, 1.62+/-0.29, and 1.3+/-0.17, respectively). In liver cirrhosis, dysplasia showed a significant relationship with ploidy (P<0.001) and AgNORs count (P<0.05).

CONCLUSION

AgNORs count and DNA ploidy analysis of core biopsy specimens are useful in the assessment of cellular kinetics of liver cirrhosis and hepatocellular carcinoma.

摘要

目的

嗜银核仁组成区(AgNOR)蛋白是一组嗜银核仁蛋白,在高度增殖的细胞中积累,而在非增殖细胞中其表达非常低。本研究旨在探讨DNA流式细胞术(FCM)和AgNOR计数在评估肝硬化和肝细胞癌细胞动力学方面的潜力。

设计与方法

纳入217例小针肝活检标本,取自84例肝细胞癌(HCC)患者(一份活检标本取自肿瘤病变,另一份取自残余非肿瘤)肝脏组织。49例肝硬化患者仅取一份活检标本。活检标本的一部分进行流式细胞术检测,另一部分进行组织病理学检查和AgNOR计数。

结果

44.5%的肝硬化患者和78.6%的肿瘤部位显示非整倍体。与二倍体病例相比,非整倍体HCC病例的AgNOR计数较高(3.407±1.18对1.74±0.9)。与残余肝组织、肝硬化和正常肝脏相比,肿瘤病变中的AgNOR计数显著增加(P<0.001)(分别为3.89±0.827、1.49±0.52、1.62±0.29和1.3±0.17)。在肝硬化中,发育异常与倍体(P<0.001)和AgNOR计数(P<0.05)显示出显著相关性。

结论

核心活检标本的AgNOR计数和DNA倍体分析有助于评估肝硬化和肝细胞癌的细胞动力学。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验